Atjaunināt sīkdatņu piekrišanu

Immunotherapy for Gastrointestinal Malignancies 2020 ed. [Hardback]

  • Formāts: Hardback, 251 pages, height x width: 235x155 mm, weight: 613 g, 27 Illustrations, color; 7 Illustrations, black and white; XII, 251 p. 34 illus., 27 illus. in color., 1 Hardback
  • Sērija : Diagnostics and Therapeutic Advances in GI Malignancies
  • Izdošanas datums: 01-Feb-2021
  • Izdevniecība: Springer Verlag, Singapore
  • ISBN-10: 9811564868
  • ISBN-13: 9789811564864
Citas grāmatas par šo tēmu:
  • Hardback
  • Cena: 154,01 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Standarta cena: 181,19 €
  • Ietaupiet 15%
  • Grāmatu piegādes laiks ir 3-4 nedēļas, ja grāmata ir uz vietas izdevniecības noliktavā. Ja izdevējam nepieciešams publicēt jaunu tirāžu, grāmatas piegāde var aizkavēties.
  • Daudzums:
  • Ielikt grozā
  • Piegādes laiks - 4-6 nedēļas
  • Pievienot vēlmju sarakstam
  • Formāts: Hardback, 251 pages, height x width: 235x155 mm, weight: 613 g, 27 Illustrations, color; 7 Illustrations, black and white; XII, 251 p. 34 illus., 27 illus. in color., 1 Hardback
  • Sērija : Diagnostics and Therapeutic Advances in GI Malignancies
  • Izdošanas datums: 01-Feb-2021
  • Izdevniecība: Springer Verlag, Singapore
  • ISBN-10: 9811564868
  • ISBN-13: 9789811564864
Citas grāmatas par šo tēmu:

 

This book reviews current immunotherapeutic strategies for gastrointestinal (GI) malignancies, including immune composition, immune checkpoint inhibitors, cell therapy, and peptide vaccines used to protect against esophageal, gastric, hepato-biliary, pancreatic and colorectal cancers. It also discusses the current challenges of using immunotherapy for the treatment of gastrointestinal malignancies.

 

The book reviews highly sensitive and specific immunomarkers for the detection of GI malignancies, and examines therapeutic vaccines and the major cytokines involved in GI immunotherapy, as well as their basic biology and clinical applications. In closing, the book explores various aspects of computational biology for the detection and treatment of GI malignancies. 


1 Tumor Heterogeneity: Challenges and Perspectives for Gastrointestinal Cancer Therapy
1(16)
Manoj Kumar Gupta
Gayatri Gouda
Ravindra Donde
Ramakrishna Vadde
2 Immunocomposition of Gastrointestinal Tract of Gut
17(24)
Mekapogu Madakka
Nambi Rajesh
Jinka Rajeswari
3 Immunomarkers for Detection of GI Malignancies
41(10)
Ravikiran Tekupalli
Santosh Anand
Sowbhagya Ramachandregowda
Anupama Sindhghatta Kariyappa
Bhagyalakshmi Dundaiah
4 Immunotherapeutics of Gastrointestinal Malignancies
51(10)
Nakka Venkata Prasuja
5 Immune Cell Therapy Against Gastrointestinal Tract Cancers
61(18)
Ravindra Donde
Manoj Kumar Gupta
Gayatri Gouda
Sushanta Kumar Dash
Lambodar Behera
Ramakrishna Vadde
6 Immune Checkpoint Inhibitors in Gastrointestinal Malignancies
79(18)
Padmaraju Vasudevaraju
Malla Rama Rao
7 Monoclonal Antibody Therapy Against Gastrointestinal Tract Cancers
97(16)
Gayatri Gouda
Manoj Kumar Gupta
Ravindra Donde
Lambodar Behera
Ramakrishna Vadde
8 Therapeutic Vaccines for Gastrointestinal Malignancies
113(46)
Bonala Sabeerabi
Venkat R. Arva Tatireddygari
Ramakrishna Vadde
9 Immuno-Oncology of Oesophageal Cancer
159(12)
Bindu Prasuna Aloor
Senthilkumar Rajagopal
10 Association Between IL6 Gene Polymorphisms and Gastric Cancer Risk: A Meta-Analysis of Case-Control Studies
171(12)
Henu Kumar Verma
Neha Merchant
L. V. K. S. Bhaskar
11 Immuno-Oncology of Colorectal Cancer
183(22)
Ramachandra Reddy Pamuru
K. V. Sucharitha
Ramakrishna Vadde
12 Immune Targets in Colorectal Cancer
205(26)
Begum Dariya
Ganji Pumachandra Nagaraju
13 Applications of Computational Biology in Gastrointestinal Malignancies
231
Manoj Kumar Gupta
Ramakrishna Vadde
Dr Vadde Ramakrishna is an Assistant Professor at the Department of Biotechnology & Bioinformatics, Yogi Vemana University, India. He obtained his MSc and PhD, both in Biochemistry, from Sri Krishnadevaraya University, Anantapur, India, and subsequently received a DBT CREST Award to pursue advanced training in cancer research at Pennsylvania State University and Colorado State University, USA. He is currently using in vitro, in vivo and in silico models to explore the role of dietary bioactive compounds in both the development and prevention of cancer through a polypharmacology approach. He has published over 75 research papers in prominent international journals and has presented more than 40 papers at national and international conferences. He serves as an editorial board member for several international journals, and is an Associate Fellow of Andhra Pradesh Akademi of Sciences.





 





Dr Ganji PurnachandraNagaraju is a faculty member at the Department of Hematology and Medical Oncology, Emory University School of Medicine. Holding a DSc from Berhampur University in Berhampur, India, his research focuses on translational projects concerning gastrointestinal malignancies. He has published over 90 research papers in prominent international journals and has presented more than 50 papers at national and international conferences. Dr Nagaraju is the author and editor of several books and serves as an editorial board member for numerous academic journals. He is an associate member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute, and has received several international awards for his contributions.